Dana-Farber Cancer Institute estimates that the freestanding cancer hospital it will construct in partnership with Beth Israel Deaconess Medical Center in Boston will cost $1.68 billion, according to Becker’s.
The systems announced the Dana-Farber Beth Israel Deaconess Cancer Collaboration. Under the agreement, the proposed adult cancer hospital will operate under the license of Dana-Farber while each organization remains fully independent.
The hospital will have 300 beds and measure at approximately 688,100 square feet, according to a legal notice. It will be constructed in Boston’s Longwood Medical Area and connect to Dana-Farber’s existing facility. Dana-Farber plans to relocate 30 inpatient beds from a space that it currently shares with Brigham and Women’s Hospital.
Dana-Farber Cancer Institute and Brigham and Women’s Hospital have been clinically affiliated since 1997 and their current agreement runs through 2028. Read more.
